Interstitial cystitis: bladder pain and beyond

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2008-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14656560802519845PMID 19006474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interstitial cystitis

  2012cited by this paper
• Treatment Approaches for Painful Bladder Syndrome/Interstitial Cystitis

  2012cited by this paper
• Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions?

  2008cited by this paper
• What is new in bladder pain syndrome/interstitial cystitis?

  2008cited by this paper
• Quantifying mast cells in bladder pain syndrome by immunohistochemical analysis

  2008cited by this paper
• A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis

  2008cited by this paper
• Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study.

  2008cited by this paper
• Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women.

  2008influential reference
• Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome.

  2008cited by this paper
• The role of cystoscopy in the diagnosis of Hunner's ulcer disease.

  2008cited by this paper
• Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndrome.

  2008cited by this paper
• Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek--an oral multi-agent natural supplement.

  2008cited by this paper
• Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal.

  2008cited by this paper
• Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis.

  2008cited by this paper
• Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin.

  2008cited by this paper
• Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlation

  2008cited by this paper
• Sites of pain from interstitial cystitis/painful bladder syndrome.

  2008cited by this paper
• Prevalence of self-reported interstitial cystitis (IC) and interstitial-cystitis-like symptoms among adult women in the community

  2007cited by this paper
• The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis.

  2007cited by this paper
• Recognition Sites for Microbes and Components of the Immune System on Human Mast Cells: Relationship to CD Antigens and Implications for Host Defense

  2007cited by this paper
• A rational combination of intravesical and systemic agents for the treatment of interstitial cystitis

  2007cited by this paper
• Fact or fiction--is abuse prevalent in patients with interstitial cystitis? Results from a community survey and clinic population.

  2007cited by this paper
• Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review.

  2007cited by this paper
• Changes in urine markers and symptoms after bladder distention for interstitial cystitis.

  2007cited by this paper
• Comorbid clinical conditions in chronic fatigue

  2007cited by this paper
• Discovery of morphological subgroups that correlate with severity of symptoms in interstitial cystitis: a proposed biopsy classification system.

  2007cited by this paper
• The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study.

  2007influential reference
• Assessing urgency in interstitial cystitis/painful bladder syndrome.

  2007cited by this paper
• Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project.

  2007cited by this paper
• Symptoms and cystoscopic findings in patients with untreated interstitial cystitis.

  2006cited by this paper
• Development of glomerulations in younger women with interstitial cystitis.

  2006cited by this paper
• Factors predisposing women to chronic pelvic pain: systematic review

  2006influential reference
• Urinary and serologic markers for interstitial cystitis: an update

  2006cited by this paper
• The management of interstitial cystitis: an update

  2006cited by this paper
• A new classification is needed for pelvic pain syndromes--are existing terminologies of spurious diagnostic authority bad for patients?

  2006cited by this paper
• Tumor necrosis factor promotes differential trafficking of bladder mast cells in neurogenic cystitis.

  2006cited by this paper
• Re: cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study.

  2006cited by this paper
• Responsiveness of symptom scales for interstitial cystitis.

  2006cited by this paper
• Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants.

  2006cited by this paper
• Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis?

  2005cited by this paper
• Immunomodulators for treatment of interstitial cystitis.

  2005cited by this paper
• Human Mast Cells Express Corticotropin-Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of Vascular Endothelial Growth Factor1

  2005cited by this paper
• Absence of bacterial and viral DNA in bladder biopsies from patients with interstitial cystitis/chronic pelvic pain syndrome.

  2005cited by this paper
• Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case-control study.

  2005cited by this paper
• Prevalence of clinically confirmed interstitial cystitis in women: a population based study in Finland.

  2005cited by this paper
• A Pilot Open Label Study of Cystoprotek® in Interstitial Cystitis

  2005cited by this paper
• Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells

  2005cited by this paper
• Efficacy of prednisone for severe refractory ulcerative interstitial cystitis.

  2005cited by this paper
• Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis discomfort, side-effects and treatment outcome

  2005cited by this paper
• Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis.

  2005cited by this paper
• Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.

  2005cited by this paper
• Preliminary Results of Suburothelial Injection of Botulinum A Toxin in the Treatment of Chronic Interstitial Cystitis

  2005cited by this paper
• APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis

  2005cited by this paper
• Prevalence and incidence of interstitial cystitis in a managed care population.

  2005cited by this paper
• International Consultation on IC—Rome, September 2004/Forging an International Consensus: Progress in Painful Bladder Syndrome/Interstitial Cystitis

  2005cited by this paper
• A prospective, double‐blind, randomized cross‐over study evaluating changes in urinary pH for relieving the symptoms of interstitial cystitis

  2005cited by this paper
• Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis.

  2005cited by this paper
• Is the potassium sensitivity test a valid and useful test for the diagnosis of interstitial cystitis?

  2005cited by this paper
• Risk factors for painful bladder syndrome in women seeking gynecologic care

  2005cited by this paper
• Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study.

  2005cited by this paper
• Menstrual cycle affects bladder pain sensation in subjects with interstitial cystitis.

  2005cited by this paper
• Abnormal urinary potassium metabolism in patients with interstitial cystitis.

  2005cited by this paper
• Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis.

  2005cited by this paper
• Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity.

  2005cited by this paper
• Increased prevalence of interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy.

  2005cited by this paper
• Correlation between 2 interstitial cystitis symptom instruments.

  2005influential reference
• International Consultation on IC – Rome, September 2004 / Forging an International Consensus: Progress in Painful Bladder Syndrome / Interstitial cystitis

  2005cited by this paper
• What is the value of cystoscopy with hydrodistension for interstitial cystitis?

  2005cited by this paper
• The prevalence of interstitial cystitis, endometriosis, adhesions, and vulvar pain in women with chronic pelvic pain.

  2005cited by this paper
• What is the pain of interstitial cystitis like?

  2005cited by this paper
• Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office.

  2005cited by this paper
• Critical role of mast cells in inflammatory diseases and the effect of acute stress.

  2004cited by this paper
• Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors.

  2004cited by this paper
• Interstitial cystitis and panic disorder: a potential genetic syndrome.

  2004cited by this paper
• Primary evaluation of patients suspected of having interstitial cystitis (IC).

  2004influential reference
• A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis.

  2004cited by this paper
• Mast cells as targets of corticotropin-releasing factor and related peptides.

  2004cited by this paper
• Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis.

  2004cited by this paper
• Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells.

  2004cited by this paper
• An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide.

  2004cited by this paper
• Corticotropin releasing factor: a mediator of emotional influences on bladder function.

  2004influential reference
• Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis

  2004cited by this paper
• Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis.

  2004cited by this paper
• Interstitial cystitis, chronic nonbacterial prostatitis and chronic pelvic pain syndrome in men: a common and frequently identical clinical entity.

  2004cited by this paper
• Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis.

  2004cited by this paper
• Comorbidity of interstitial cystitis with other unexplained clinical conditions.

  2004cited by this paper
• Interstitial cystitis: a chronic pelvic pain syndrome.

  2004cited by this paper
• Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis.

  2004cited by this paper
• Future research needs for the definition/diagnosis of interstitial cystitis

  2003cited by this paper
• A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.

  2003cited by this paper
• The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

  2003influential reference
• Intercurrent Autoimmune Conditions in Classic and Non-ulcer Interstitial Cystitis

  2003cited by this paper
• Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study.

  2003cited by this paper
• Neuroimmune Connections and Regulation of Function in the Urinary Bladder

  2003cited by this paper
• Significance of complications of allergic diseases in young patients with interstitial cystitis

  2003cited by this paper
• A comparison of multiple urine markers for interstitial cystitis.

  2002influential reference
• Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha.

  2002cited by this paper
• The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

  2002cited by this paper
• Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity.

  2002cited by this paper
• Current management of interstitial cystitis.

  2002influential reference

• Personalized insights into urinary tract infection management: A text mining analysis of online consultation data

  2025cites this paper
• Therapeutic Effect of a Composite Acellular Matrix/Hyaluronic Acid Thermosensitive Hydrogel for the Interstitial Cystitis/Bladder Pain Syndrome in a Rat Model.

  2025cites this paper
• A Critical Review on Quercetin Bioflavonoid and its Derivatives: Scope, Synthesis, and Biological Applications with Future Prospects

  2023cites this paper
• SuperGAG biopolymers for treatment of excessive bladder permeability

  2021cites this paper
• Effectiveness of Acceptance and Commitment Therapy in Central Pain Sensitization Syndromes: A Systematic Review

  2021cites this paper
• Cystitis and Interstitial Cystitis/Painful Bladder Syndrome

  2020cites this paper
• Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/interstitial cystitis – significance in the responsiveness to antihistamine treatment and disease symptoms

  2019cites this paper
• Minimally Invasive Therapy for Bladder Pain Syndrome (Interstitial Cystitis)

  2018cites this paper
• Anti-Allergic Compounds in Chronic Pelvic Pain

  2017cites this paper
• Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome

  2017cites this paper
• Contrast-Enhanced Magnetic Resonance Imaging (CE-MRI) as a Diagnostic Tool for Assessing Bladder Permeability and Associated Colon Cross-Talk: Pre-Clinical Studies in a Rat Model

  2016cites this paper
• Contrast enhanced magnetic resonance imaging as a diagnostic tool to assess bladder permeability and associated colon cross talk: preclinical studies in a rat model.

  2015cites this paper
• Chemistry, Biochemistry and Pharmacology of Hydrogen Sulfide

  2015cites this paper
• The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome

  2015cites this paper
• H2S and Pain: A Novel Aspect for Processing of Somatic, Visceral and Neuropathic Pain Signals.

  2015cites this paper
• Reduction of oxidative stress may play a role in the anti‐inflammatory effect of the novel herbal formulation in a rat model of hydrochloric acid‐induced cystitis

  2015cites this paper
• The effect of spinal cord injury on vagal afferents.

  2014cites this paper
• Pulmonary , gastrointestinal and urogenital pharmacology Evaluation of selective cannabinoid CB 1 and CB 2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis

  2014cites this paper
• Available evidence about efficacy of different restoring agents of glycosaminoglycans for intravesical use in interstitial cystitis

  2013cites this paper
• Procédés pour le traitement de la douleur pelvienne et/ou d'affections comorbides

  2013cites this paper
• Evidencia disponible relativa a la eficacia de diferentes agentes endovesicales restituidores de glucosaminoglicanos empleados en cistitis intersticial

  2013cites this paper
• Convergence and cross talk in urogenital neural circuitries.

  2013cites this paper
• Endometrial stem cell differentiation into smooth muscle cell: a novel approach for bladder tissue engineering in women

  2013cites this paper
• [Available evidence about efficacy of different restoring agents of glycosaminoglycans for intravesical use in interstitial cystitis].

  2013cites this paper
• Key role of CRF in the skin stress response system.

  2013cites this paper
• Involvement of the endogenous hydrogen sulfide/Cav3.2 T‐type Ca2+ channel pathway in cystitis‐related bladder pain in mice

  2012cites this paper
• Minimally Invasive Therapy for Interstitial Cystitis/Painful Bladder Syndrome

  2012cites this paper
• Review of Interstitial Cystitis and Need for Therapeutic Strategy Using Traditional Korean Medicine

  2012cites this paper
• Th e symptom profi le and comorbidities associated with this painful condition can make it diffi cult to diagnose— unless you know what to look for.

  2011cites this paper
• When to suspect interstitial cystitis.

  2011cites this paper
• Interstitial cystitis is associated with vulvodynia and sexual dysfunction--a case-control study.

  2011cites this paper
• MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome.

  2010cites this paper
• Visceral organ cross-sensitization - an integrated perspective.

  2010influential citation
• Medicolegal Issues 77 . Stolen prescription medical reports part 2 : still cause for alarm

  2010cites this paper
• A droplet-based building block approach for bladder smooth muscle cell (SMC) proliferation

  2010cites this paper
• Interstitial cystitis patients’ use and rating of complementary and alternative medicine therapies

  2010cites this paper
• Corticotropin‐releasing hormone‐receptor 2 is required for acute stress‐induced bladder vascular permeability and release of vascular endothelial growth factor

  2010cites this paper
• Minimally Invasive Therapies for Chronic Pelvic Pain Syndrome

  2010cites this paper
• Differential purinergic signaling in bladder sensory neurons of naïve and bladder‐inflamed mice

  2010cites this paper
• Painful bladder syndrome: Is consensus possible?

  2009cites this paper
• Painful bladder syndrome: Is consensus possible?

  2009cites this paper
• Involvement of purinergic P2X and P2Y2 receptors in urinary bladder sensation

  2009cites this paper
• Effects of estrogens and bladder inflammation on mitogen-activated protein kinases in lumbosacral dorsal root ganglia from adult female rats

  2009cites this paper
• Risk factors for poor sleep quality among patients with interstitial cystitis in Taiwan

  2009cites this paper
• The ‘sweet’ and ‘bitter’ involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance

  2009influential citation